Почетна › Метастатски карцином › Kolorado › Denver
Kliničke studije za Метастатски карцином u gradu Denver, CO
25 studija za Метастатски карцином traži učesnike na lokacijama u gradu Denver i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Clinical Study Site, Denver
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- SCRI at HealthOne, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthOne, Denver
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Тражи се учесникФаза 3
- AdventHealth Medical Group - Porter, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthONE, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Тражи се учесникФаза 1/2
- Avenzo Therapeutics Recruiting Site, Denver
A Study of ASP3082 in Adults With Advanced Solid Tumors
Тражи се учесникФаза 1
- Denver HealthONE Drug Development Unit, Denver
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Тражи се учесникФаза 1/2
- UCHealth Cherry Creek Medical Center, Denver
- Rocky Mountain Cancer Centers,LLP, Denver
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Тражи се учесникФаза 3
- Intermountain Health Cancer Center Saint Joseph, Denver
- Intermountain Health Saint Joseph Hospital - Research Office, Denver
- Intermountain Health Saint Joseph Hospital, Denver
- и још 3
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Тражи се учесникФаза 3
- AdventHealth Medical Group - Porter, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Тражи се учесникФаза 1/2
- Rocky Mountain Cancer Center, Denver
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Тражи се учесникФаза 3
- Research Site, Denver
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Тражи се учесникФаза 1/2
- University of Colorado Cancer Center, Denver
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute Denver, Denver
A Study of PYX-201 in Advanced Solid Tumors
Тражи се учесникФаза 1
- SCRI - HealthOne Denver, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Тражи се учесникФаза 2/3
- The Melanoma & Skin Cancer Institute, Englewood · 6 ми удаљено
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Тражи се учесникФаза 1
- Sarah Cannon Research Institute at HealthONE, Denver
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Тражи се учесникФаза 1/2
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Тражи се учесникОпсервациона студија
- Massive Bio SYNERGY-AI site, Denver
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Тражи се учесникФаза 1
- SCRI Denver Drug Development Unit, Denver
Studije za Метастатски карцином u drugim gradovima
- Houston, TX100 студија
- New York City, NY93 студија
- Nashville, TN69 студија
- Boston, MA61 студија
- Los Angeles, CA57 студија
- Arlington, VA52 студија
- St. Louis, MO52 студија
- San Antonio, TX44 студија
- Washington, DC44 студија
- Dallas, TX44 студија
- Philadelphia, PA42 студија
- Chicago, IL42 студија
Ostale studije u gradu Denver
- Рак дојке26 студија
- Многи мијелом26 студија
- Немалоклетни карцином плућа25 студија
- Колоректални карцином22 студија
- Меланом19 студија
- Рак простате19 студија
- Рак јајника17 студија
- Карцином ендометријума15 студија
- Рак (све врсте)15 студија
- Рак плућа15 студија
- Не-Ходжкинов лимфом14 студија
- Рак панкреаса13 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.